Rice Hall James & Associates, LLC Global Blood Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$22.3 - $37.39 $3.4 Million - $5.7 Million	-152,317 Reduced 39.69%	231,435 $7.39 Million
Q1 2022 May 05, 2022	BUY	$25.68 - $35.59 $211,449 - $293,048	8,234 Added 2.19%	383,752 $13.3 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $853,148 - $1.38 Million	-34,263 Reduced 8.36%	375,518 $11 Million
Q3 2021 Nov 09, 2021	BUY	$25.48 - $37.34 $1.56 Million - $2.28 Million	61,162 Added 17.54%	409,781 $10.4 Million
Q2 2021 Jul 29, 2021	SELL	$32.46 - $43.42 $1.65 Million - $2.2 Million	-50,686 Reduced 12.69%	348,619 $12.2 Million
Q1 2021 May 14, 2021	BUY	$38.94 - $50.85 $229,356 - $299,506	5,890 Added 1.5%	399,305 $16.3 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $2.73 Million - $4.62 Million	72,488 Added 22.59%	393,415 $17 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $4.29 Million - $6.06 Million	81,320 Added 33.94%	320,927 $17.7 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $845,562 - $1.42 Million	17,352 Added 7.81%	239,607 $15.1 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $316,946 - $662,458	-7,597 Reduced 3.31%	222,255 $11.4 Million
Q4 2019 Jan 29, 2020	SELL	$45.7 - $81.86 $270,087 - $483,792	-5,910 Reduced 2.51%	229,852 $18.3 Million
Q3 2019 Oct 30, 2019	BUY	$45.35 - $57.91 $4.38 Million - $5.6 Million	96,642 Added 69.47%	235,762 $11.4 Million
Q2 2019 Aug 01, 2019	BUY	$52.6 - $63.29 $7.32 Million - $8.8 Million	139,120 New	139,120 $7.32 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.